Literature DB >> 16123549

Intravitreal staining of the internal limiting membrane using indocyanine green in the treatment of macular holes.

Eduardo B Rodrigues1, Carsten H Meyer, Michel E Farah, Peter Kroll.   

Abstract

Surgical management of macular holes consists of pars plana vitrectomy, removal of the posterior hyaloid facia, and peeling of the epiretinal membranes (ERM). Additionally, removal of the internal limiting membrane (ILM) may enable an increase in the anatomic and functional success rates. However, recognition of fine ILM is difficult thus increasing the time that the macula is exposed to intraoperative light. Staining the ILM with indocyanine green (ICG) dye during vitrectomy facilitates recognition of the ILM and assures that all adjacent ERM are removed. Therefore, ICG-assisted ILM peeling has gained worldwide popularity among vitreoretinal surgeons. However, there are some concerns about the intravitreal ICG application. Reports in the literature described a variety of application techniques using different concentrations. The postoperative outcomes were controversial reporting heterogeneous anatomical and functional outcomes after ICG application, as well as descriptions of adverse effects related to the dye. We discuss the indications, techniques, surgical results, and complications after intravitreal ICG injection for the treatment of macular holes. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123549     DOI: 10.1159/000086107

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  8 in total

1.  Soluble lutein in combination with brilliant blue as a new dye for chromovitrectomy.

Authors:  Emmerson Badaro; Bruno Furlani; Juliana Prazeres; Mauricio Maia; Acácio Alves Souza Lima; Diogo Souza-Martins; Cristina Muccioli; Luiz Filipe Adami Lucatto; Rubens Belfort
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-19       Impact factor: 3.117

Review 2.  Chromovitrectomy.

Authors:  Ovidiu Musat; Cornel Stefan; Ana-Maria Boariu; Diana Colta; Corina Cernat; Lucian Alexandru; Raluca Diana Georgescu; Ioana Stella Patoni; Cristina Mihaela Timaru; Simone De Algerino
Journal:  Rom J Ophthalmol       Date:  2016 Apr-Jun

3.  Investigation of the retinal biocompatibility of acid violet for chromovitrectomy.

Authors:  Emmerson Badaró Cardoso; Milton Moraes-Filho; Eduardo B Rodrigues; Mauricio Maia; Fernando M Penha; Eduardo Amorim Novais; Rodrigo A Souza-Lima; Carsten H Meyer; Michel Eid Farah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-18       Impact factor: 3.117

4.  Outcomes of 23-gauge pars plana vitrectomy and internal limiting membrane peeling with brilliant blue in macular hole.

Authors:  Huseyin Sanisoglu; Mehmet Sahin Sevim; Betul Aktas; Semra Sevim; Ahmet Nohutcu
Journal:  Clin Ophthalmol       Date:  2011-08-19

Review 5.  Complications of Macular Peeling.

Authors:  Mónica Asencio-Duran; Beatriz Manzano-Muñoz; José Luis Vallejo-García; Jesús García-Martínez
Journal:  J Ophthalmol       Date:  2015-09-03       Impact factor: 1.909

6.  Retinal biocompatibility of brilliant blue g with deuterated water for chromovitrectomy.

Authors:  Emmerson Badaró; Milton Moraes-Filho; Mauricio Maia; Fernando M Penha; Eduardo Amorim Novais; Rodrigo A Souza-Lima; Flavio Hirai; Carsten H Meyer; Michel Eid Farah; Eduardo B Rodrigues
Journal:  J Ophthalmic Vis Res       Date:  2014-04

7.  Investigation of new dyes for chromovitrectomy: preclinical biocompatibility of trisodium, orangell and methyl violet.

Authors:  Emmerson Badaro; Rodrigo A Souza-Lima; Eduardo A Novais; Mauricio Maia; Flávio Hirai; Carsten H Meyer; Michel Eid Farah; Eduardo B Rodrigues
Journal:  Int J Retina Vitreous       Date:  2015-04-15

Review 8.  Management of recurrent rhegmatogenous retinal detachment.

Authors:  Manish Nagpal; Pranita Chaudhary; Shachi Wachasundar; Ahmed Eltayib; Aparajita Raihan
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.